Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
80.28
-3.84 (-4.56%)
Feb 21, 2025, 4:00 PM EST - Market closed
Globus Medical Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Globus Medical stock have an average target of 96.91, with a low estimate of 90 and a high estimate of 115. The average target predicts an increase of 20.71% from the current stock price of 80.28.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Globus Medical stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 5 | 4 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 3 | 3 | 3 | 2 | 3 | 3 |
| Sell | 0 | 0 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 14 | 14 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $92 → $94 | Strong Buy | Maintains | $92 → $94 | +17.09% | Feb 21, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $95 → $93 | Buy | Maintains | $95 → $93 | +15.84% | Feb 21, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 21, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 6, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $92 → $101 | Strong Buy | Maintains | $92 → $101 | +25.81% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
2.56B
from 1.57B
Increased by 62.96%
Revenue Next Year
2.73B
from 2.56B
Increased by 6.61%
EPS This Year
3.05
from 1.07
Increased by 185.22%
EPS Next Year
3.50
from 3.05
Increased by 14.80%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.6B | 2.8B | 3.0B | ||
| Avg | 2.6B | 2.7B | 2.9B | ||
| Low | 2.4B | 2.6B | 2.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 68.6% | 10.5% | 11.2% | ||
| Avg | 63.0% | 6.6% | 6.9% | ||
| Low | 55.6% | 1.3% | -0.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.34 | 3.78 | 4.52 | ||
| Avg | 3.05 | 3.50 | 4.01 | ||
| Low | 2.87 | 3.20 | 3.46 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 212.1% | 23.9% | 28.9% | ||
| Avg | 185.2% | 14.8% | 14.3% | ||
| Low | 168.4% | 5.0% | -1.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.